CFR section

21 CFR 600.81: Distribution reports

PART 600-BIOLOGICAL PRODUCTS: GENERAL · Subpart D-Reporting of Adverse Experiences

Key facts

Citation 21 CFR 600.81
Section Distribution reports
Part PART 600-BIOLOGICAL PRODUCTS: GENERAL
Subpart Subpart D-Reporting of Adverse Experiences
Subchapter 21 CFR F Biologics
Product types cited Biologics, Drugs

At a glance

  • 1–9 Inspections citing this section
  • None Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA